Future analysis should focus on elucidating the oncogenic pathways upstream of RSK4 that are shared between cancer types where it acts as a tumour promoter or suppressor to better understand what determines the differential outputs from this kinase. This evidence concerns the gene RPS6KA6 and neoplasm.